Jessica Erriquez

Dr. Jessica Erriquez

Fondazione del Piemonte per l'Oncologia - IRCCS
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2015 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
EZEugenia R. Zanella
Eugenia R. Zanella
FGFrancesco Galimi
Francesco Galimi
FSFrancesco Sassi
Francesco Sassi
GMGiorgia Migliardi
Giorgia Migliardi
FCFrancesca Cottino
Francesca Cottino
ABAndrea Bertotti
Andrea Bertotti
Colorectal cancers that display reduced sensitivity to EGFR inhibition and strong IGF2 overexpression can be effectively treated by dual EGFR/IGF2 blockade.

1 March 2012 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
VBV. Bolis
V. Bolis
CBC. Busco
C. Busco
MCM. Ciarletta
M. Ciarletta
CDCarla Distasi
Carla Distasi
JEJessica Erriquez
Jessica Erriquez
SMS. Morel
S. Morel

28 August 2013 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
SPSimona Pavan
Simona Pavan
DMDaniele Musiani
Daniele Musiani
ETErica Torchiaro
Erica Torchiaro
GMGiorgia Migliardi
Giorgia Migliardi
MGMarta Gai
Marta Gai
MRMaria Flavia Di Renzo
Maria Flavia Di Renzo
The hepatocyte growth factor (HGF) also known as scatter factor activates cancer cell invasion and metastasis. We show that in ovarian cancer cells HGF induced the phosphorylation of the small heat shock protein of 27 kDa (HSP27) by activating the p38MAPK. HSP27 is increased in many cancers at advanced stage including ovarian cancer and associated with cancer resistance to therapy and poor patients' survival. The phosphorylation of HSP27 regulates both its chaperone activity and its control of cytoskeletal stability. We show that HSP27 was necessary for the remodeling of actin filaments induced by HGF and that motility in vitro depended on the p38MAPK‐MK2 axis. In vivo, HSP27 silencing impaired the ability of the highly metastatic, HGF‐secreting ovarian cancer cells to give rise to spontaneous metastases. This was due to defective motility across the vessel wall and reduced growth. Indeed, HSP27 silencing impaired the ability of circulating ovarian cancer cells to home to the lungs and to form experimental hematogenous metastases and the capability of cancer cells to grow as subcutaneous xenografts. Moreover, HSP27 suppression resulted in the sensitization of xenografts to low doses of the chemotherapeutic paclitaxel, likely because HSP27 protected microtubules from bundling caused by the drug. Altogether, these data show that the HSP27 is required for the proinvasive and prometastatic activity of HGF and suggest that HSP27 might be not only a marker of progression of ovarian cancer, but also a suitable target for therapy.

Verified
Journal Article
Open access
PDF file
SCSonia Capellero
Sonia Capellero
JEJessica Erriquez
Jessica Erriquez
CBChiara Battistini
Chiara Battistini
RPRoberta Porporato
Roberta Porporato
GSGiulia Scotto
Giulia Scotto
MOMartina Olivero
Martina Olivero
Peritoneal metastases are the leading cause of morbidity and mortality in ovarian cancer. Cancer cells float in peritoneal fluid, named ascites, together with a definitely higher number of non neo-neoplastic cells, as single cells or multicellular aggregates. The aim of this work is to uncover the features that make these aggregates the metastasizing units. Immunofluorescence revealed that aggregates are made almost exclusively of ovarian cancer cells expressing the specific nuclear PAX8 protein. The same cells expressed epithelial and mesenchymal markers, such as EPCAM and αSMA, respectively. Expression of fibronectin further supported a hybrid epithelia-mesenchymal phenotype, that is maintained when aggregates are cultivated and proliferate. Hematopoietic cells as well as macrophages are negligible in the aggregates, while abundant in the ascitic fluid confirming their prominent role in establishing an eco-system necessary for the survival of ovarian cancer cells. Using ovarian cancer cell lines, we show that cells forming 3D structures neo-expressed thoroughly fibronectin and αSMA. Functional assays showed that αSMA and fibronectin are necessary for the compaction and survival of 3D structures. Altogether these data show that metastasizing units display a hybrid phenotype that allows maintenance of the 3D structures and the plasticity necessary for implant and seeding into peritoneal lining.

1 September 2015 in Gynecologic Oncology
Verified
Journal Article
Closed access
JEJessica Erriquez
Jessica Erriquez
PBP. Becco
P. Becco
MOMartina Olivero
Martina Olivero
Riccardo PonzoneRiccardo Ponzone
Riccardo Ponzone
FMF. Maggiorotto
F. Maggiorotto
Giorgio ValabregaGiorgio Valabrega
Giorgio Valabrega

10 January 2006 in The FASEB Journal
Verified
Journal Article
Closed access
PDF file
RBR. A. Billington
R. A. Billington
EBE. A. Bellomo
E. A. Bellomo
EFE. M. Floriddia
E. M. Floriddia
JEJessica Erriquez
Jessica Erriquez
CDCarla Distasi
Carla Distasi
AGA. A. Genazzani
A. A. Genazzani